超声微泡携带基因治疗血管再狭窄的研究进展

www.yongyao.net　　2009-9-27 15:50:22　　来源：　　责任编辑：

分享到：

[ 参考文献]
[ 1 ] 　Daemen J ,Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus2eluting and paclitaxel2eluting stents in routine clinical p ractice: data from a large two2institutional cohort study [ J ]. Lancet, 2007, 369(9562) : 667-678.
[ 2 ] 　Taniyama Y, Tachibana K, Hiraoka K. Local delivery of p lasmid DNA into ratcarotid artery using ultrasound[ J ]. Circulation, 2002, 105: 1233-1239.
[ 3 ] 　李　玲,王志刚. 超声微泡造影剂携带基因治疗与超声空化效应[ J ]. 临床超声医学杂志, 2005, 7 (3 ) : 195-197.
[ 4 ] 　Hwang JH,B rayman AA, ReidyMA, et al. Vascular effects induced by combined 12MHz ultrasound and microbubble contrast agent treatments in vivo [ J ]. UltrasoundMed B iol, 2005, 31 (4) : 553-564.
[ 5 ] 　Shohet RV, Chen SY, Zhou YT, et al. Echocardiographic destruction of albumin
microbubbles directs gene delivery to themyocardium [ J ]. Circulation, 2000, 101(22) : 2554-2556.
[ 6 ] 　刘玉凤,任卫东,唐　力,等. 超声介导声诺维提高人血管内皮细胞基因转染效率的体外实验研究[ J ]. 中国医学影像技术, 2006, 22 (2) : 177-179.
[ 7 ] 　KinoshitaM, Hynynen K. A novelmethod for the intracellular delivery of siRNAusingmicrobubble2enhanced focused ultrasound[ J ]. B iochem B iophys Res Commun, 2005, 335 (2) : 393-399.
[ 8 ] 　Yla2Herttuala S, R issanen TT,Vajanto I, et al. Vascular endothelial growth factors: biology and current status of clinical app lications in cardiovascularmedicine[ J ]. J Am Coll Cardiol, 2007, 49 (10) : 1015-1026.
[ 9 ] 　Asahara T, Chen DH, Tsurami Y, et al. Accelerated restitution of endothelial integrity and endothelium2dependent function after phVEGF165 gene transfer[ J ].Circulation, 1996, 94 (12) : 3291-3302.
[ 10 ] 　Belle EV, Tio FO, Chen DH, et al. Passivation of metallic stents after arterialgene transfer of phVEGF165 inhibits thrombus formation and intimal thickening[ J ]. J Am Coll Cardiol, 1997, 29 (6) : 1371-1379.
[ 11 ] 　HedmanM, Hartikainen J , Yla2Herttuala S, et al. Safety and feasibility of catheter2based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangiop lasty and in2stent restenosis and in the treatment of chronic myocardial ischemia: phase Ⅱ results of the Kuop io Angiogenesis Trial(KAT) [ J ]. Circulation, 2003, 107 (21) : 2677-2683.
[ 12 ] 　凌智瑜,王志刚,冉海涛,等. 超声微泡造影剂介导VEGF基因治疗大鼠心肌缺血的实验性研究[ J ]. 中国超声医学杂志, 2002, 18 (7) : 502-504.
[ 13 ] 　Korpanty G, Chen S, Shohet RV, et al. Targeting ofVEGF2mediated angiogenesis to ratmyocardium using ultrasonic destruction ofmicrobubbles[ J ]. Gene Ther, 2005, 12 (17) : 130521312.
[ 14 ] 　ScheinmanM,A scher E,Levi GS, et al. p53 gene transfer to the injured rat carotid artery decreases neointimal formation[ J ]. J Vasc Surg, 1999, 29 (2) : 360-369.
[ 15 ] 　Teupe C, Richter S, FisslthalerB, et al. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase ( S1177D) using ultrasound2enhanced destruction of p lasmid2loaded microbubbles imp roves vasoreactivity [ J ]. Circulation, 2002, 105 (9) : 1104-1109.
[ 16 ] 　KutrykMJ , Foley DP, van den B randM, et al. Local intracoronary administration of antisense oligonucleotide against cmyc for the p revention of in2stent restenosis: results of the randomized investigation by the thoraxcenter of antisenseDNA using local delivery and IVUS after coronary stenting ( ITAL ICS) trial[ J ]. J Am Coll Cardiol, 2002, 39 (2) : 281-287.
[ 17 ] 　Kip shidze NN, Porter TR, Dangas G, et al. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model [ J ]. Cardiovasc Revasc Med,2003, 4 (3) : 152-159.
[ 18 ] 　Porter TR, Xie F, Knapp D, et al. Targeted vascular delivery of antisense molecules using intravenous microbubbles [ J ]. Cardiovasc Revasc Med, 2006, 7(1) : 25-33.
[ 19 ] 　L i SH, Szmitko PE,Weisel RD, et al. C2reactive p rotein up regulates comp lement2inhibitory factors in endothelial cells[ J ]. Circulation, 2004, 109 (7) : 833-836.
[ 20 ] 　Anderson DR, Tsutsui JM, Xie F, et al. The role of comp lement in the adherence of microbubbles to dysfunctional arterial endothelium and atheroscleroticp laque[ J ]. Cardiovasc Res, 2007, 73 (3) : 597-606.
[ 21 ] 　Morishita R, Gibbons GH, HoriuchiM, et al. A gene therapy strategy using atranscrip tion factor decoy of the E2F binding site inhibits smooth muscle p roliferation in vivo[ J ]. Proc NatlAcad SciUSA, 1995, 92 (13) : 5855-5859.
[ 22 ] 　Hashiya N, AokiM, Tachibana K, et al. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound withmicrobubble agent (Op tison) inhibits intimal hyperp lasia after balloon injury in rat carotid artery model [ J ]. B iochemB iophys Res Commun, 2004, 317: 508-514.
[ 23 ] 　Inagaki H, Suzuki J ,OgawaM, et al. U ltrasound2microbubble2mediated NFkappaB decoy transfection attenuates neointimal formation after arterial injury in mice[ J ]. J Vasc Res, 2006, 43 (1) : 12-18.
[ 24 ] 　刘伊丽. 对比超声学[M ]. 北京:人民卫生出版社, 2006. 2332247.
[ 25 ] 　Vlaskou D,Mykhaylyk O, Giunta R, et al. Magnetic microbubbles: new carriersfor localized gene and drug delivery[ J ]. Mol Ther, 2006, 13: S290.